| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| George I Papakostas, Susan G Kornstein, Anita H Clayton, Claudio N Soares, Lindsay A Hallett, Alok Krishen, Vivian L Tucke. Relative antidepressant efficacy of bupropion and the selective serotonin reuptake inhibitors in major depressive disorder: gender-age interactions. International clinical psychopharmacology. vol 22. issue 4. 2007-07-24. PMID:17519646. |
specifically, more women treated with a selective serotonin reuptake inhibitor experienced a 50% or greater decrease in hamilton depression rating scale anxiety-somatization scores (58.8 versus 63.8%, p=0.0394). |
2007-07-24 |
2023-08-12 |
Not clear |
| George I Papakostas, Susan G Kornstein, Anita H Clayton, Claudio N Soares, Lindsay A Hallett, Alok Krishen, Vivian L Tucke. Relative antidepressant efficacy of bupropion and the selective serotonin reuptake inhibitors in major depressive disorder: gender-age interactions. International clinical psychopharmacology. vol 22. issue 4. 2007-07-24. PMID:17519646. |
no difference, however, was seen in the degree of resolution of hamilton depression rating scale anxiety-somatization scores (continuous measure) between women treated with bupropion versus a selective serotonin reuptake inhibitor (p=0.114). |
2007-07-24 |
2023-08-12 |
Not clear |
| George I Papakostas, Susan G Kornstein, Anita H Clayton, Claudio N Soares, Lindsay A Hallett, Alok Krishen, Vivian L Tucke. Relative antidepressant efficacy of bupropion and the selective serotonin reuptake inhibitors in major depressive disorder: gender-age interactions. International clinical psychopharmacology. vol 22. issue 4. 2007-07-24. PMID:17519646. |
bupropion and the selective serotonin reuptake inhibitors, thus, appear to be equally effective in treating depressive symptoms, as well as anxious/somatic symptoms and insomnia in depression. |
2007-07-24 |
2023-08-12 |
Not clear |
| George I Papakostas, Susan G Kornstein, Anita H Clayton, Claudio N Soares, Lindsay A Hallett, Alok Krishen, Vivian L Tucke. Relative antidepressant efficacy of bupropion and the selective serotonin reuptake inhibitors in major depressive disorder: gender-age interactions. International clinical psychopharmacology. vol 22. issue 4. 2007-07-24. PMID:17519646. |
no gender-related or age-related differences were found except that greater improvement was seen in anxious/somatic symptoms of depression among women during selective serotonin reuptake inhibitor treatment. |
2007-07-24 |
2023-08-12 |
Not clear |
| Ian Goodyer, Bernadka Dubicka, Paul Wilkinson, Raphael Kelvin, Chris Roberts, Sarah Byford, Siobhan Breen, Claire Ford, Barbara Barrett, Alison Leech, Justine Rothwell, Lydia White, Richard Harringto. Selective serotonin reuptake inhibitors (SSRIs) and routine specialist care with and without cognitive behaviour therapy in adolescents with major depression: randomised controlled trial. BMJ (Clinical research ed.). vol 335. issue 7611. 2007-07-24. PMID:17556431. |
selective serotonin reuptake inhibitors (ssris) and routine specialist care with and without cognitive behaviour therapy in adolescents with major depression: randomised controlled trial. |
2007-07-24 |
2023-08-12 |
Not clear |
| Ian Goodyer, Bernadka Dubicka, Paul Wilkinson, Raphael Kelvin, Chris Roberts, Sarah Byford, Siobhan Breen, Claire Ford, Barbara Barrett, Alison Leech, Justine Rothwell, Lydia White, Richard Harringto. Selective serotonin reuptake inhibitors (SSRIs) and routine specialist care with and without cognitive behaviour therapy in adolescents with major depression: randomised controlled trial. BMJ (Clinical research ed.). vol 335. issue 7611. 2007-07-24. PMID:17556431. |
to determine whether a combination of a selective serotonin reuptake inhibitor (ssris) and cognitive behaviour therapy (cbt) together with clinical care is more effective in the short term than an ssri and clinical care alone in adolescents with moderate to severe major depression. |
2007-07-24 |
2023-08-12 |
Not clear |
| David A Cousins, Allan H Youn. The armamentarium of treatments for bipolar disorder: a review of the literature. The international journal of neuropsychopharmacology. vol 10. issue 3. 2007-07-20. PMID:17176493. |
however, data are emerging for the efficacy of selective serotonin reuptake inhibitors for bipolar depression in combination with atypical antipsychotics. |
2007-07-20 |
2023-08-12 |
Not clear |
| Xian-Zhang Hu, A John Rush, Dennis Charney, Alexander F Wilson, Alexa J M Sorant, George J Papanicolaou, Maurizio Fava, Madhukar H Trivedi, Stephen R Wisniewski, Gonzalo Laje, Silvia Paddock, Francis J McMahon, Husseini Manji, Robert H Lipsk. Association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression. Archives of general psychiatry. vol 64. issue 7. 2007-07-20. PMID:17606812. |
association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression. |
2007-07-20 |
2023-08-12 |
Not clear |
| Chi-Un Pae, Chul Lee, In-Ho Pai. Therapeutic implication of cocaine- and amphetamine-regulated transcript (CART) in the treatment of depression. Medical hypotheses. vol 69. issue 1. 2007-07-18. PMID:17196760. |
the regulation of the signal transduction pathways by cart by modulating neurotrophic factors, such as brain-derived neurotrophic factor (bdnf), kinases (trkb), and neurotransmitters (5-ht), can also contribute to the treatment of depression. |
2007-07-18 |
2023-08-12 |
Not clear |
| Vincenzo De Luca, Olga Likhodi, James L Kennedy, Albert H C Won. Differential expression and parent-of-origin effect of the 5-HT2A receptor gene C102T polymorphism: analysis of suicidality in schizophrenia and bipolar disorder. American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics. vol 144B. issue 3. 2007-07-18. PMID:17221840. |
the serotonin 2a (5-ht2a) receptor gene has been implicated in the pathogenesis of suicidal behavior by a genetic association between the 5-ht2a c102t silent polymorphism and suicidality in patients with major depression. |
2007-07-18 |
2023-08-12 |
human |
| Kim Smits, Luc Smits, Frenk Peeters, Jan Schouten, Rob Janssen, Hubert Smeets, Jim van Os, Martin Prin. Serotonin transporter polymorphisms and the occurrence of adverse events during treatment with selective serotonin reuptake inhibitors. International clinical psychopharmacology. vol 22. issue 3. 2007-07-16. PMID:17414739. |
we included 214 patients meeting diagnostic and statistical manual of mental disorder-iv criteria for major depression and using an selective serotonin reuptake inhibitor for at least 6 weeks. |
2007-07-16 |
2023-08-12 |
Not clear |
| Laurent Holzer, Pierre Bauman. Selective serotonin reuptake inhibitors in adolescent depression still controversial. Journal of clinical psychopharmacology. vol 27. issue 3. 2007-07-13. PMID:17502798. |
selective serotonin reuptake inhibitors in adolescent depression still controversial. |
2007-07-13 |
2023-08-12 |
Not clear |
| Anne M Libby, David A Brent, Elaine H Morrato, Heather D Orton, Richard Allen, Robert J Valuc. Decline in treatment of pediatric depression after FDA advisory on risk of suicidality with SSRIs. The American journal of psychiatry. vol 164. issue 6. 2007-07-12. PMID:17541047. |
in october 2003, the u.s. food and drug administration (fda) issued a public health advisory about the risk of suicidality in pediatric patients taking selective serotonin reuptake inhibitors (ssris) for depression. |
2007-07-12 |
2023-08-12 |
Not clear |
| Tomas de Pauli. Drug evaluation: Vilazodone--a combined SSRI and 5-HT1A partial agonist for the treatment of depression. IDrugs : the investigational drugs journal. vol 10. issue 3. 2007-07-10. PMID:17351874. |
vilazodone is a combined selective serotonin reuptake inhibitor (ssri) and a 5-ht(1a) receptor partial agonist that is being developed by clinical data inc for the treatment of depression. |
2007-07-10 |
2023-08-12 |
rat |
| Consuelo Mejías, Elvira Rodríguez-Pinilla, Paloma Fernández Martín, María Luisa Martínez-Fría. [Adverse effects of selective serotonin reuptake inhibitors use during the third trimester of pregnancy and prevention guidelines]. Medicina clinica. vol 128. issue 15. 2007-07-09. PMID:17462198. |
selective serotonin reuptake inhibitors (ssris) have become the drug of choice for the treatment of depression and have shown to be effective in the treatment for other mental disorders. |
2007-07-09 |
2023-08-12 |
Not clear |
| Mikko Joensuu, Tommi Tolmunen, Pirjo I Saarinen, Jari Tiihonen, Jyrki Kuikka, Pasi Ahola, Ritva Vanninen, Johannes Lehtone. Reduced midbrain serotonin transporter availability in drug-naïve patients with depression measured by SERT-specific [(123)I] nor-beta-CIT SPECT imaging. Psychiatry research. vol 154. issue 2. 2007-07-03. PMID:17289353. |
reduced midbrain serotonin transporter availability in drug-naïve patients with depression measured by sert-specific [(123)i] nor-beta-cit spect imaging. |
2007-07-03 |
2023-08-12 |
Not clear |
| Mikko Joensuu, Tommi Tolmunen, Pirjo I Saarinen, Jari Tiihonen, Jyrki Kuikka, Pasi Ahola, Ritva Vanninen, Johannes Lehtone. Reduced midbrain serotonin transporter availability in drug-naïve patients with depression measured by SERT-specific [(123)I] nor-beta-CIT SPECT imaging. Psychiatry research. vol 154. issue 2. 2007-07-03. PMID:17289353. |
earlier results have indicated that serotonin transporter (sert) availability is altered in major depression. |
2007-07-03 |
2023-08-12 |
Not clear |
| b' Ricard Navin\\xc3\\xa9s, Roc\\xc3\\xado Mart\\xc3\\xadn-Santos, Esther G\\xc3\\xb3mez-Gil, Mar\\xc3\\xada J Mart\\xc3\\xadnez de Osaba, M Luisa Imaz, Crist\\xc3\\xb3bal Gast\\xc3\\xb. Effects of citalopram treatment on hypothermic and hormonal responses to the 5-HT1A receptor agonist buspirone in patients with major depression and therapeutic response. Psychoneuroendocrinology. vol 32. issue 4. 2007-07-03. PMID:17337123.' |
serotonin (5-ht) 5-ht1a receptor seems to play an important role in the pathophysiology of major depression and in the mechanism of action of antidepressants. |
2007-07-03 |
2023-08-12 |
Not clear |
| Noreen Samad, Darakhshan Jabeen Halee. Serotonin-1A receptor responsiveness in stress and following adaptation to stress. Pakistan journal of pharmaceutical sciences. vol 20. issue 2. 2007-07-03. PMID:17416565. |
a deficiency of serotonin (5-hydroxytryptamine; 5-ht) is described in human depression. |
2007-07-03 |
2023-08-12 |
human |
| Noreen Samad, Darakhshan Jabeen Halee. Serotonin-1A receptor responsiveness in stress and following adaptation to stress. Pakistan journal of pharmaceutical sciences. vol 20. issue 2. 2007-07-03. PMID:17416565. |
the results are discussed in the context of stress-induced psychiatric disorder such as, depression and its treatment by 5-ht 1a agonist. |
2007-07-03 |
2023-08-12 |
human |